TY - JOUR
AU - Mattheis, Martha J.
AB - As part of a large study designed to develop schedules for smallpox immunization with reduced morbidity, 799 children received primary immunization with subcutaneous vaccine. Four vaccines (New York City Board of Health calf lymph, New York City chorioallantoic membrane, CV-1, and Lister) at three dosages (103, 104, 105 pockforming units) were administered. Eighty-two percent responded with hemagglutination- inhibiting antibody at one month, and only 22% with neutralizing antibody. There was no correlation between concentration of vaccine and antibody response. The CV-1 strain was slightly but significantly less likely to induce antibody than the other three vaccines. Subcutaneous vaccination was not associated with significant temperature elevation in general. However, some children developed erythema at the vaccination site or a swollen arm, and fever did tend to occur in this small group. Four children developed nonspecific vaccinia-related rashes, and one had generalized vaccinia.
TI - Primary Subcutaneous Vaccination
JF - The Journal of Infectious Diseases
DO - 10.1093/infdis/135.1.167
DA - 1977-01-01
UR - https://www.deepdyve.com/lp/oxford-university-press/primary-subcutaneous-vaccination-ElfrSenNh6
SP - 167
EP - 175
VL - 135
IS - 1
DP - DeepDyve
ER -